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Modulation of Intestinal Epithelial Glycocalyx Development
by Human Milk Oligosaccharides and Non-Digestible
Carbohydrates
Chunli Kong,* Marlies Elderman, Lianghui Cheng, Bart J. de Haan, Arjen Nauta,
and Paul de Vos
Scope: The epithelial glycocalyx development is of great importance for
microbial colonization. Human milk oligosaccharides (hMOs) and
non-digestible carbohydrates (NDCs) may modulate glycocalyx
development.
Methods and results: The eﬀects of hMOs and NDCs on human gut epithelial
cells (Caco2) are investigated by quantifying thickness and area coverage of
adsorbed albumin, heparan sulfate (HS), and hyaluronic acid (HA) in the
glycocalyx. Eﬀects of hMOs (2′-FL and 3-FL) and NDCs [inulins with degrees
of polymerization (DP) (DP3-DP10, DP10-DP60, DP30-DP60) and pectins with
degrees of methylation (DM) (DM7, DM55, DM69)] are tested using
immunoﬂuorescence staining at 1 and 5 days stimulation. HMOs show a
signiﬁcant enhancing eﬀect on glycocalyx development but eﬀects are
structure-dependent. 3-FL induces a stronger albumin adsorption and
increases HS and HA stronger than 2′-FL. The DP3-DP10, DP30-60 inulins
also increase glycocalyx development in a structure-dependent manner as
DP3-DP10 selectively increases HS, while DP30-DP60 speciﬁcally increases
HA. Pectins have less eﬀects, and only increase albumin adsorption.
Conclusion: Here, it is shown that 2′-FL and 3-FL and inulins stimulate
glycocalyx development in a structure-dependent fashion. This may
contribute to formulation of eﬀective hMO and NDC formulations in infant
formulas to support microbial colonization and gut barrier function.
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Breastfeeding is considered the golden
standard for supply of nutrients and
bioactive molecules to neonates. Im-
portant mother milk components for
neonatal gastrointestinal development
are the human milk oligosaccharides
(hMOs). hMOs have been shown to
shape the microbiome within the gas-
trointestinal tract;[1,2] reduce pathogenic
infections by serving as decoy for
pathogens;[3,4] stimulate the immune
system of infants, and enhance intestinal
barrier function.[5] However, there are
still about 70% of the infants that cannot
be solely fed with breastfeeding for a va-
riety of reasons.[6] These infants receive
cow milk derived infant formulas, in
which often non-digestible carbohydrates
(NDCs) such as inulins and pectins are
included to mimic some functions of
hMOs.[7] To even more closely mimic the
compositions of mother milk, signiﬁcant
attempts have been made to synthesize
hMOs for supplementation in infant for-
mulas. Some of these molecules can be
produced in a cost-eﬀective way, making application in infant
formulas a realistic option.[8]
One important function of hMOs and NDCs in infant formula
is stimulation of colonization of the gastrointestinal tract by mi-
crobiota and promote development of gut barrier function.[9,10] A
possible way by which this is accomplished is by stimulating the
development of the epithelial glycocalyx on gut epithelial cells.
The glycocalyx on neonatal gut epithelium provides binding sites
for the commensal microorganisms and a well-developed glyco-
calyx may prevent adhesion of pathogens and serve as a barrier
for luminal toxins and enzymes.[11,12] The glycocalyx is composed
of glycans and proteins. Proteoglycans are generally considered
the most important component of the glycocalyx and form the
skeleton of the glycocalyx.[13] In addition, the glycocalyx contains
glycosaminoglycan chains which are linked to the core protein
of the proteoglycans.[13] Heparan sulfate (HS) and hyaluronic
acid (HA) are the predominant glycosaminoglycan components
in glycocalyx.[14] HS is a linear highly sulfated polysaccharide
that is composed of repeating disaccharide units that consist
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of an O-sulfated derivative of glucosamine and an uronic
acid.[15] HA is a non-sulfated disaccharide polymer, lacking the
complex chemical structure of HS and is much longer than
HS.[16]
If the glycocalyx components are not properly developed itmay
lead to enhanced chances for gastrointestinal disorders.[17] The
diﬀerent glycocalyx molecules can contribute in diﬀerent ways
to gut homeostasis. HS can mediate cell signaling by binding
numerous extracellular ligands such as ﬁbroblast growth factor
and contributes to homeostasis of innate immunity.[18,19] HA
is highly viscous and forms a physical barrier on top of the gut
epithelium.[20,21] In dextran sodium sulfate induced colitis, HA
expression is enhanced to support colonic epithelial repair.[22]
Inﬂammatory bowel disease can be caused by modiﬁcation
of the glycosaminoglycan composition and distribution on
gut epithelium.[17] Proteins adsorbed on glycosaminoglycan
also play an important role in the stability of the glycocalyx.
When protein adsorption is absent, the interactions within the
glycocalyx collapse and barrier function is lost.[14] Especially
absence of albumin induces collapse and shedding of the
glycocalyx.[23]
As not much information is available about eﬀects of hMOs
and NDCs on glycocalyx development, we performed this study
to determine whether and to what extent these molecules inﬂu-
ence glycocalyx synthesis by human gut epithelial cells. To this
end, we stimulated gut epithelial Caco2 cells for 1 and 5 days with
diﬀerent hMOs and NDCs. Eﬀects were tested on adsorbed albu-
min, HS, and HA and average thickness and average area cov-
erage of the glycocalyx layer components on gut epithelial cells.
We tested eﬀects of the hMOs 2′-FL (2′-fucosyllactose; Fucα1, 2-
Galβ1, 4Glc) and 3-FL (3-fucosyllactose; Galβ1, 4(Fucα1, 3) Glc).
Eﬀects were compared withmolecules that are often used as sub-
stitutes for hMOs in infant formula. To this end we tested inulins
with three diﬀerent degrees of polymerization (DP) (DP3-DP10,
DP10-DP60, DP30-60) and pectins with three diﬀerent degrees of
methylation (DM) (DM7, DM55, DM69) in order to gain insight
in chemical structure–eﬀects relationships.
2. Experimental Section
2.1. Carbohydrates
The human milk oligosaccharides (hMOs), 2′-FL was provided
by FrieslandCampina Domo (the Netherlands) and 3-FL was pro-
vided by Glycosyn LLC (Woburn, MA, USA). Commercially ex-
tracted chicory inulins with diﬀerent degrees of polymerization
range (DP3-DP10, DP10-DP60, and DP30-60) were provided by
Sensus (theNetherlands). DP3-DP10 is of the highly soluble pow-
dered Frutaﬁt CLR inulins, which was produced from partially
hydrolyzed chicory inulin. DP10-DP60 andDP30-DP60 are of the
moderate soluble powdered Frutaﬁt TEX! inulins. Lemon origi-
nated pectinswith diﬀerent degrees ofmethylation (DM7,DM55,
and DM69) were obtained from CP Kelco (Denmark). Endotoxin
levels in the eight samples were analyzed by endotoxin detection
kit (Thermo Fisher Scientiﬁc), and all fell below the endotoxin
detection level of 0.1 ng mL−1. All of the carbohydrates were dis-
solved to 2 mgmL−1 in cell culture media before stimulation. Af-
ter optimization by comparing concentrations of 2, 5, and 10 mg
mL−1 in a pilot study, a slight, gradual increasing eﬀect was ob-
served when the concentration increased. As 2 mg mL−1 elicited
a response allowing quantiﬁcation in time, 2mgmL−1 was ﬁnally
chosen.[24,25]
2.2. Cell Culture
Human colon carcinoma Caco2 cells were incubated with 5%
CO2 at 37 °C in Dulbecco’s Modiﬁed Eagle Medium (DMEM,
Lonza), supplemented with 10% v/v fetal calf serum (FCS, In-
vitrogen), 1% v/v non-essential amino acid (NEAA, Sigma), 50 U
mL−1 Penicillin (Sigma), 50 µg mL−1 Streptomycin (Sigma), and
2.5% v/v HEPES (Sigma) to maintain a stable pH environment.
The cells density was adjusted to 1.6 × 104 mL−1 before being
seeded onto the 8-well Lab-Tek Chamber Slide (w/Cover, Nunc,
Thermo Fisher Scientiﬁc). To improve the adhesion of cells to the
slide, 200 µL of poly-l-lysine solution (Sigma) was applied to pre-
coat the slide. After 2 days of growth, the cells were stimulated
with the eight types of carbohydrates for 1 or 5 days.
2.3. Immunoﬂuorescence Staining
For staining of albumin, the following procedure was ap-
plied. After stimulation with carbohydrates, Caco2 monolay-
ers were washed with 1× Dulbecco’s phosphate-buﬀered saline
(DPBS), ﬁxed with 2% paraformaldehyde/0.1% glutaraldehyde
for 30 min, and blocked with 2% donkey serum for 30 min at
room temperature. After overnight incubation with anti-albumin
(rabbit IgG, 1:150, Invitrogen) at 4 °C, cells were washed with 1×
DPBS for three times and incubated with Alexa Fluor 555 don-
key anti-rabbit secondary antibody (1:400, molecular probes) in
the dark for another 30 min, followed by washing three times
with 1× DPBS.
The HS staining procedure was the same as the staining for
albumin, except that the cells were incubated overnight with Ab-
Heparan Sulfate F58-10E4 (1:100, amsbio) at 4 °C, and after wash-
ing three times with 1 × DPBS, the cells were incubated with
Alexa Fluor 488 donkey anti-mouse secondary antibody (1:100,
molecular probes) in the dark for 30 min.
HA staining was also performed in virtually the same way as
the staining for albumin, but the cells were blocked with 2% goat
serum for 30 min and incubated overnight with hyaluronic acid
binding protein (HABP, 50 µg mL−1, Calbiochem) at 4 °C. Af-
ter three times washing with 1 × DPBS, the cells were incu-
bated with Streptavidin FITC (1:100, eBioscience) in the dark for
30 min.
DAPI (1:5000, Sigma) staining in the dark for 10 min was ap-
plied to stain the nuclei of Caco2 cells. This was done after the
staining of the glycocalyx layer components, followed by wash-
ing three times with 1 × DPBS. Then the chamber frame was
removed, cells on the slide were mounted with CitiFluor (Elec-
tron Microscopy Sciences), and covered with glass coverslip. For
all of the three glycocalyx layer components, the control groups
were incubated with 1 × DPBS overnight at 4 °C instead of the
primary antibodies. For the negative control group, the primary
and secondary antibodies were both replaced with 1 × DPBS.
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Figure 1. Glycocalyx thickness analysis. A) The merged images of the maximum intensity from the Z-projection of the FITC (green) and DAPI (blue)
channels. B) The orthogonal views of the FITC channel. C) We applied the threshold value determined from the corresponding control and negative
control groups to include all of the green channel of the XZ-axis of this plane. At least 10 XZ and YZ slices were chosen for quantiﬁcation of each image.
Scale bar = 20 µm.
2.4. Confocal Microscopy
All the images were captured with a Leica SP8 confocal laser
microscope (Leica Microsystems, Wetzlar, Germany) with the
64×/1.4 oil DIC objective. Albumin was excited at 555 nm and
emitted at 580–650 nm (red); HS and HA were excited at 488
nm, and emitted at 500–580 nm (green); DAPI was excited at 405
nm, and emitted at 420–460 nm (blue). Z-stack (512-× 512- pixel
resolution × 8 bit) images of each ﬁeld of view (FOV, 246.51 ×
246.51 µm2) were taken with a step length of 1.0 µm from the
bottom to the top of the monolayer. At least three images were
taken of each sample in one experiment.
The average thickness of the glycocalyx components was
quantiﬁed according to the method of using the ImageJ software
(Version 1.51n; National Institutes of Health, USA) as shown in
Figure 1.[26] The staining ofHA is shown in Figure 1A as an exam-
ple of merged images of the maximum intensity plane from the
Z-projection of the FITC (green) and DAPI (blue) channels. The
green and blue channels were split, and then focus was turned to
the orthogonal views of the green channel (Figure 1B). Along the
XZ-axis, the threshold value can be adjusted to cover the green
channel with red color (Figure 1C). The threshold values for all
the images quantiﬁcation were determined from the correspond-
ing control and negative control groups as follows: the pixel inten-
sity histograms from themaximum intensityZ-projections of the
control and negative control were introduced to one curve, and
the intersection point was deﬁned as the threshold value that was
applied for the data analysis. At least 10 XZ and YZ slices were
chosen of each image to do the quantiﬁcation. As for one experi-
ment, at least three images were taken, and at least six individual
experiments were done. There were at least 360 slices involved
in the average thickness quantiﬁcation. The average thickness of
each slice of the green channel was calculated as Equation (1).
Average thickness = Total area
Total length
(1)
All of the Z-stack images taken by the Leica SP8 confocal mi-
croscope (at least 18 images for each sample) were applied to
quantify the average area of each glycocalyx layer component us-
ing IMARIS software (Version 8.0, Bitplane, Switzerland). There
were two channels in total. The blue (DAPI) channel was for the
quantiﬁcation of the total number of the cells of each image; The
green (FITC, for example) channel can be split out to quantify the
total area of the staining. The threshold value of the green chan-
nel was adjusted to include the whole staining. The average area
was expressed as Equation (2).
Average area = Total area
Total number of cells
(2)
2.5. Statistical Analysis
Data analysis was done by GraphPad Prism 6 statistical soft-
ware (GraphPad Prism Software Inc. San Diego, CA, USA). The
Kolmogorov–Smirnov test was applied to determine normality
of data distribution. Results were expressed as mean ± SD. All
data were ﬁnally analyzed with Kruskal–Wallis test of one-way
ANOVA. Signiﬁcant diﬀerence level was deﬁned as p < 0.05
(*p < 0.05, **p < 0.01), p < 0.1 was considered to be a statistical
trend.
3. Results
The glycocalyx layer of gut epithelial cells is the primary site for
adhesion of commensal bacteria. Its compositions and develop-
ment are important for building up of the intestine barrier and a
normal gut microbiota.[27] As human milk oligosaccharides are
involved in stimulating gut microﬂora,[28] we tested whether this
may happen via stimulation of the development of the glycocalyx
on gut epithelial cells that form anchoring points for gut bacteria.
Mol. Nutr. Food Res. 2019, 63, 1900303 1900303 (3 of 10) C© 2019 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
www.advancedsciencenews.com www.mnf-journal.com
Figure 2. The glycocalyx layer compositions of Caco2 cells were modiﬁed by hMOs at 1 day of culture. Caco2 cells were stimulated with hMOs. These
were 2’-FL and 3-FL tested at 2 mg mL−1 for 1 day. Untreated Caco2 cells served as controls. After incubation, we applied immunoﬂuorescence to label
the glycocalyx layer components albumin, HS, and HA. 3D images were taken with a Leica SP8 confocal laser microscope. The average thickness of A)
albumin, C) HS, and E) HA were quantiﬁed using ImageJ software of the 3D images. The average area of cells covered with B) albumin, D) HS, and
F) HA were measured with IMARIS software of the 3D images. All data were expressed as mean with standard deviation from six replicates. Statistical
signiﬁcance was tested using one-way ANOVA (*p < 0.05, **p < 0.01).
The glycocalyx major constituents are HS and HA chains.[16]
In the human body albumin provides stability to the glycoca-
lyx. Albumin is synthesized in the liver, and adsorbed on gut
epithelial cells.[29] It can be found in the small intestine[30] and
contributes to the structure of the glycocalyx layer.[31] Albumin
was also present in the culture medium and could therefore also
be studied. We tested the eﬀects of the hMOs 2′-FL and 3-FL,
inulins with DPs of DP3-DP10, DP10-DP60, and DP30-60, and
lemon pectins with DMs of DM7, DM55, andDM69. The average
thickness and average area of albumin, HS, and HA components
around the cells that were covered with glycocalyx were quanti-
ﬁed. This was done after 1 day and 5 days of culture to follow the
development of the glycocalyx when the gut epithelial cells were
exposed to the hMOs and NDCs.
3.1. The Glycocalyx Layer Compositions of Caco2 Cells After
1 Day and 5 Days Exposure to hMOs
The hMOs 2′-FL and 3-FL were tested ﬁrst. After 1 day and 5 days
stimulation with 2 mg mL−1, the cells were stained for albumin,
HS, and HA on Caco2 epithelial cells.
After 1 day of stimulation, both 2′-FL and 3-FL hMOs signiﬁ-
cantly increased the thickness of the albumin layer in the glyco-
calyx (p< 0.01, Figure 2A). The average area coverage by albumin
was almost doubled by the hMOs but only 3-FL reached statistical
signiﬁcant levels (p < 0.01, Figure 2B).
There was a tendency that the average thickness of HS was
also increased by the hMOs after 1 day of stimulation (p < 0.10,
Figure 2C). The average area of cells that were covered with HS
was increased by the hMOs, but the magnitude of increase was
hMOs-type dependent and only reached statistical signiﬁcance
with 3-FL (p < 0.05, Figure 2D).
There was no eﬀect on the average thickness of HA of the two
hMOs (Figure 2E). However, the average area of cells covered
with theHA-component was increased by both 2′-FL and 3-FL but
only 3-FL reached statistical signiﬁcance (p < 0.05, Figure 2F).
A duration of 5 days exposure to the hMOs resulted in a sta-
ble glycocalyx layer. The average thickness of albumin was sig-
niﬁcantly improved by the 2′-FL (p < 0.05, Figure 3A) and 3-FL
(p < 0.01, Figure 3A). The average area of cells covered with al-
bumin was also increased by the hMOs, while 2′-FL reached sta-
tistical signiﬁcance (p < 0.01, Figure 3B).
Both 2′-FL and 3-FL increased the average thickness of the gly-
cocalyx layer that contains HS, but only 3-FL hMO showed sig-
niﬁcant eﬀects (p < 0.01, Figure 3C). The average area that was
covered with HS component was not inﬂuenced by the hMOs
(Figure 3D).
The 3-FL almost doubled the average area of cells that were
covered with HA but did not reach statistical signiﬁcance
(Figure 3F).
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Figure 3. The glycocalyx layer compositions of Caco2 cells were modiﬁed after 5 days of exposure to hMOs. Caco2 cells were stimulated with hMOs.
These were 2’-FL and 3-FL tested at 2 mg mL−1 for 5 days. Untreated Caco2 cells served as controls. After incubation, we applied immunoﬂuorescence
to label the glycocalyx layer components albumin, HS, and HA. 3D images were taken with a Leica SP8 confocal laser microscope. The average thickness
of A) albumin, C) HS, and E) HA were quantiﬁed using ImageJ software of the 3D images. The average area of cells covered with B) albumin, D) HS, and
F) HA were measured with IMARIS software of the 3D images. All data were expressed as mean with standard deviation from six replicates. Statistical
signiﬁcance was tested using one-way ANOVA (*p < 0.05, **p < 0.01).
3.2. The Glycocalyx Layer Compositions of Caco2 Cells After
1 Day and 5 Days Exposure to Inulins
Inulins are often used as substitute for hMOs in infant formulas.
Inulins vary in composition in diﬀerent infant formulations and
were therefore tested in three diﬀerent DP compositions. Inulins
with DP3-DP10, DP10-DP60, and DP30-60 were incubated with
Caco2 cells at a concentration of 2 mg mL−1. After 1 day and 5
days of culture, the cells were stained and analyzed for the aver-
age thickness and average area of the glycocalyx.
A pronounced development of the glycocalyx was already ob-
served after day 1. After 1 day of stimulation, DP3-DP10, DP10-
DP60, and DP30-60 inulins all signiﬁcantly increased the aver-
age thickness of the glycocalyx layer that contains the albumin
(p < 0.05, Figure 4A). There was no DP dependent eﬀect of the
inulins on adsorbed albumin.
The average thickness of the HS component was also in-
creased by the inulins but only reached statistical signiﬁcance
with inulins DP3-DP10 (p < 0.05, Figure 4C). The average area
that was covered by HS was almost doubled by the inulins but
was not more than a statistical trend (p < 0.1, Figure 4D).
The average thickness of the HA was not inﬂuenced by the
inulins (Figure 4E) but the average coverage of the cells with HA
was increased in a DP-dependent manner. The long chain DP30-
DP60 had the most pronounced eﬀect and almost doubled HA
on the cells (p < 0.05, Figure 4F).
A period of 5 days exposure resulted in a more pronounced ef-
fect of the inulins. DP3-DP10, DP10-DP60, and DP30-DP60 in-
ulins all signiﬁcantly increased the average thickness of the albu-
min component (p < 0.05, Figure 5A), while they only showed
a slight increased eﬀect on the average coverage of the albumin
(Figure 5B).
The average thickness of HS component was also increased by
the inulins after 5 days stimulation, but it only reached statisti-
cal signiﬁcance after DP3-DP10 (p < 0.01, Figure 5C) and DP10-
DP60 (p < 0.05, Figure 5C) inulin exposure. The average thick-
ness of HA was not inﬂuenced after 5 days exposure to inulin
(Figure 5E).
3.3. The Glycocalyx Layer Compositions of Caco2 Cells After
1 Day and 5 Days Exposure to Pectins
Pectin-derived oligosaccharides are another NDC source used
as supplement in infant formula.[7] Since the biological func-
tions are reported to be DM dependent,[32] pectins with diﬀerent
methylation degrees of DM7,DM55, andDM69were also applied
to stimulate Caco2 cells at a concentration of 2 mg mL−1. Cells
were harvested and stained for glycocalyx layer components after
1 day and 5 days incubation.
After 1 day stimulation, the average thickness of the albumin
was almost doubled, but this did not reach statistical signiﬁcance
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Figure 4. The glycocalyx layer compositions of Caco2 cells were modiﬁed by inulins at 1 day of culture. Caco2 cells were stimulated with diﬀerent chain
length of inulins. These were inulins with DP3-DP10, DP10-DP60, and DP30-60 tested at 2 mg mL−1 for 1 day. Untreated Caco2 cells served as controls.
After incubation, we applied immunoﬂuorescence to label the glycocalyx layer components albumin, HS, and HA. 3D images were taken with a Leica
SP8 confocal laser microscope. The average thickness of A) albumin, C) HS, and E) HA were quantiﬁed using ImageJ software of the 3D images. The
average area of cells covered with B) albumin, D) HS, and F) HA were measured with IMARIS software of the 3D images. All data were expressed as
mean with standard deviation from six replicates. Statistical signiﬁcance was tested using one-way ANOVA (*p < 0.05, **p < 0.01).
(Figure 6A). The average area of the cells covered with albumin
was increased by pectins in a DM dependent manner, in which
the low DM7 pectin signiﬁcantly increased the average area of
albumin in the glycocalyx layer (p < 0.05, Figure 6B).
The average thickness of the glycocalyx layer containing HS
was also increased but never reached statistical signiﬁcance
(Figure 6C). The pectins didn’t inﬂuence the average thickness
of HA. Although the average area of cells covered with HA was
increased by pectins, we didn’t observe any signiﬁcant diﬀerence
(Figure 6F).
After 5 days stimulation, the pectins all signiﬁcantly increased
the average thickness of albumin (p< 0.05, Figure 7A). However,
the average area coverage of albumin was not inﬂuenced by the
pectins (Figure 7B). There were no eﬀects on the development of
HS and HA components (Figure 7C–F).
4. Discussion
The intestinal epithelial glycocalyx is acknowledged for its func-
tion as initial adherence site for microbiota in infants and for
its initial barrier function toward pathogen invasion and lumi-
nal toxins.[11,12,33] Despite this pivotal function of the epithelial
glycocalyx only minor information is available about the gut
epithelial glycocalyx composition and possible eﬀects of dietary
components on the epithelial glycocalyx. Here we show, to the
best of our knowledge for the ﬁrst time, that hMOs as well as
commonly used NDCs in infant formula (inulins and pectins)
do impact the average thickness and average area coverage of the
glycocalyx on intestinal epithelial cells.[7,8]
hMOs and NDCs have for long been recognized to support
host–microbe interactions by serving as prebiotics, decoy for
pathogens, or antimicrobial agent.[3,27,34] However, they may also
impact intestinal epithelial cells directly. Here, we studied the
quantitative eﬀects and diﬀerences in impact of hMOs andNDCs
on individual glycocalyx components on the intestinal absorptive
enterocytes Caco2 cell-line.[35] The reason for choosing this cell-
type and not other commonly used cell-lines such as the HT29-
MTX cell-line is that Caco2 is not dedicated to mucus production
such as HT29-MTX that has a clear intestinal epithelial mucus-
secreting goblet-phenotype.[36] Caco2 can produce the glycocalyx
at a suﬃcient and appropriate rate to allow quantiﬁcation of time-
dependent eﬀects of the studied molecules.
The hMOs and NDCs investigated here do stimulate the
development of the glycocalyx on intestinal epithelial cells. This
may be a possible mechanism for the observed enhancing eﬀects
of hMOs and NDCs and its beneﬁcial eﬀects on gut microbiota
that need the glycocalyx to adhere to the gut epithelium, with
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Figure 5. The glycocalyx layer compositions of Caco2 cells were modiﬁed after 5 days of exposure to inulins. Caco2 cells were stimulated with diﬀerent
chain length of inulins. These were inulins with DP3-DP10, DP10-DP60, and DP30-60 tested at 2 mg mL−1 for 5 days. Untreated Caco2 cells served as
controls. After incubation, we applied immunoﬂuorescence to label the glycocalyx layer components albumin, HS, and HA. 3D images were taken with
a Leica SP8 confocal laser microscope. The average thickness of A) albumin, C) HS, and E) HA were quantiﬁed using ImageJ software of the 3D images.
The average area of cells covered with B) albumin, D) HS, and F) HA were measured with IMARIS software of the 3D images. All data were expressed
as mean with standard deviation from six replicates. Statistical signiﬁcance was tested using one-way ANOVA (*p < 0.05, **p < 0.01).
subsequent positive eﬀects on fermentation products short chain
fatty acids (SCFAs) and vitamins.[37] Also, it may be a possible
mechanistic explanation for the hMOs and NDCs induced en-
hanced gut barrier function.[5,10,38] As shown in our current study
the glycocalyx reinforcing eﬀects of the tested food ingredients
are due to direct eﬀects on the epithelial cells and not induced
by possible microbiota eﬀects as all tests were performed in the
absence of bacteria. Eﬀects on the glycocalyx are dependent on
the structure of the hMOs and NDCs as discussed below.
We show that the hMOs 2′-FL, 3-FL as well as inulins with
DP3-DP10, DP10-DP60, and DP30-DP60 signiﬁcantly increased
the average thickness of adsorbed albumin on gut epithelial cells
within 1 day of stimulation. These eﬀects in albumin uptake in
the glycocalyx are long lasting and still observed after 5 days.
Pectins had less eﬀects at day 1. Only after 5 days stimulation
with DM7, DM55, and DM69 pectins, a signiﬁcant eﬀect on al-
bumin adsorption was observed. An increase in albumin adsorp-
tion in the glycocalyx is considered to provide more stability of
the glycocalyx as other components including HS and HA are
better integrated into the glycocalyx structure by the adsorbed
protein.[14,26] Also increased albumin adsorption may contribute
to the anti-pathogenic eﬀects of the glycocalyx as it has been
shown that a supplement of albumin results in less adhesion
of, for example, Staphylococcus epidermidis, Staphylococcus aureus,
Pseudomonas aeruginosa.[39,40] An increased albumin adsorption
also contributes to enhanced barrier function as it protects during
volume resuscitation in hydroxyethyl starch solutions against ad-
verse eﬀects of hydroxyethyl starch on intestinal cells, metabolic
functions, ﬂuid shifts, and epithelial barrier permeability.[41] This
suggests that the enhancing eﬀects on albumin adsorption of
hMOs and NDCs may not only strengthen the glycocalyx struc-
ture but also protect against pathogen adhesion andmaintain un-
der luminal changes the gut epithelial barrier.
hMO 3-FL but not 2′-FL had a thickness increasing eﬀect on
HS after 5 days of stimulation. Of the tested NDCs only the
short chain inulin DP3-DP10 had such an eﬀect on HS and sig-
niﬁcantly increased the average thickness of HS on both day 1
and 5. Even though only minor information is available on func-
tional eﬀects of HS increase on intestine epithelial cells, it has
been shown for endothelial cells that a thicker HS layer pro-
vides stronger hydraulic resistance.[42] HS and HA are the major
components of glycosaminoglycan in the glycocalyx.[14] Both of
them can regulate mechanotransduction and maintain gut bar-
rier integrity.[19,43] Interestingly, just like with HS also HA in the
glycocalyx was increased by 3-FL and not by 2′-FL after 1 day
of stimulation. Of the NDCs tested only the long chain inulin
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Figure 6. The glycocalyx layer compositions of Caco2 cells were modiﬁed by pectins at 1 day of culture. Caco2 cells were stimulated with diﬀerent
methylation degrees of pectins. These were pectins with DM7, DM55, and DM69 tested at 2 mg mL−1 for 1 day. Untreated Caco2 cells served as
controls. After incubation, we applied immunoﬂuorescence to label the glycocalyx layer components albumin, HS, and HA. 3D images were taken with
a Leica SP8 confocal laser microscope. The average thickness of A) albumin, C) HS, and E) HA were quantiﬁed using ImageJ software of the 3D images.
The average area of cells covered with B) albumin, D) HS, and F) HA were measured with IMARIS software of the 3D images. All data were expressed
as mean with standard deviation from six replicates. Statistical signiﬁcance was tested using one-way ANOVA (*p < 0.05).
DP30-60 increased HA on day 1. An increased HA expression
is associated with a defense mechanism against intestinal injury
and inﬂammation.[21,22] In response to endoplasmic reticulum
stress, HA accumulates to form cable-like structure which can
serve as binding sites for leukocytes.[44] Increased HA expression
may also contribute to expedited signaling with gut microbiota,
as HA binds to toll-like receptors (TLR) 2 and 4, which are impor-
tant receptors in regulation of host responses to both commensal
and pathogenic bacteria within the gastrointestinal tract.[21] The
above observations support that both hMOs and the tested NDCs
have glycocalyx modifying eﬀects, which may be instrumental in
providing binding sites for commensals.[34]
Thus, our data demonstrate that hMOs stimulate the glyco-
calyx development in a structure-dependent manner. The reason
for choosing 2′-FL and 3-FL in our studies is that these molecules
can be produced in suﬃcient amounts to allow application of
these hMOmolecules in infant formula. In addition, 2′-FL is one
of the most abundant hMOs in mother milk.[8] Our data illus-
trate that even the structurally related 2′-FL and 3-FL had diﬀer-
ent eﬀects in the glycocalyx. The 2′-FL hMO impacted the average
thickness of the albumin layer at day 1 and 5 while 3-FL not only
increased this average thickness of albumin but also improved
the average area coverage of albumin after 1 day. This took more
time with 2′-FL that needed 5 days to signiﬁcantly increase the
average area of albumin. The average area coverage of HS and
HA were signiﬁcantly increased by 3-FL on day 1, while there is
no eﬀect after 5 days stimulation. The 3-FL also signiﬁcantly in-
creased the average thickness of HS, but no eﬀects were observed
with 2′-FL. Such a large diﬀerence in eﬀect is rather surprising
as 2′-FL and 3-FL share the same core structure and only diﬀer
in that the L-fucose of 2′-FL is fucosylated to galactose, while the
L-fucose of 3-FL is fucosylated to glucose.[8] The 3′-sialyllactose
(3′-SL) is another trisaccharide hMO that shares the same core
structure with 2′-FL and 3-FL, but diﬀer in a sialylated lactose on
3-FL.[8] Incubation of 3′-SL together with Caco2 cells have been
reported to reduce sialic acid and lactosamine expression.[25] Our
data suggest that 2′-FL and 3-FL are also able to directly modulate
the intestinal epithelial cells surfaces, and the diﬀerence in fuco-
sylation site has a signiﬁcant impact on the glycocalyx synthesis
machinery in epithelial cells.
The eﬀects of inulins on the epithelial glycocalyx were similar
to the eﬀect of 3-FL. All three tested inulin types with DPs of
DP3-DP10, DP10-DP60, and DP30-DP60 increased the average
thickness of the albumin layer after 1 day and 5 days stimulation.
The short chain DP3-DP10 inulin that is commonly applied
in infant formula already increased the average thickness of
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Figure 7. The glycocalyx layer compositions of Caco2 cells were modiﬁed after 5 days of exposure to pectins. Caco2 cells were stimulated with diﬀerent
methylation degrees of pectins. These were pectins with DM7, DM55, and DM69 tested at 2 mg mL−1 for 5 days. Untreated Caco2 cells served as
controls. After incubation, we applied immunoﬂuorescence to label the glycocalyx layer components albumin, HS, and HA. 3D images were taken with
a Leica SP8 confocal laser microscope. The average thickness of A) albumin, C) HS, and E) HA were quantiﬁed using ImageJ software of the 3D images.
The average area of cells covered with B) albumin, D) HS, and F) HA were measured with IMARIS software of the 3D images. All data were expressed
as mean with standard deviation from six replicates. Statistical signiﬁcance was tested using one-way ANOVA (*p < 0.05, **p < 0.01).
HS within 1 day.[45] Interestingly, DP30-DP60 inulin selectively
increased the average area coverage of HA within 1 day. All
these data suggest that inulins have a structure-dependent
eﬀect on the compositions and development of the glycocalyx.
Since the enhanced development of the intestinal epithelial
glycocalyx layer is associated with expedited colonization with
commensal microorganisms,[11] our results suggest that short
chain inulins may be instrumental for this eﬀects and may be
further supported with application of long chain inulins as this
increases the average area coverage of HA.
The eﬀects were diﬀerent with pectins than with hMOs and
inulins and eﬀects were DM dependent.[1,46] Only DM7 pectin
signiﬁcantly increased the average area coverage of albumin af-
ter 1 day of stimulation. After longer term exposure, that is, 5 days
to DM7, DM55, and DM69 pectins a signiﬁcant increased aver-
age thickness of albumin was observed. There was a tendency of
pectins to increase the development of HS after 1 day, but this
never reached statistical signiﬁcance. Our observations indicate
that the pectins can modulate protein adsorption but has only a
minor impact on the carbohydrate components of the glycocalyx
layer.
In summary, here we show that 2′-FL and 3-FL, and NDCs
including inulins and pectins are able to stimulate matura-
tion of the glycocalyx of intestine epithelial cells in a structure-
dependent fashion. Especially hMOs and inulins have such an
eﬀect while pectins were less eﬀective. As increased maturation
expedites colonization of the infant intestinewithmicrobiota, our
data suggest that hMOs and inulins seem both to be eﬀective
for glycocalyx development. Our data also contributes to a bet-
ter understanding of how hMOs and dietary ﬁbers contribute to
a healthier gut in infants. It shows that it not only is beneﬁcial
for microbiota by serving as carbohydrate source but also directly
stimulates maturation of the intestinal anchoring points for bac-
teria, that is, the glycocalyx.
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